Related Experiment Video
Updated: Feb 9, 2026

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
Toll-like Receptors Signaling Pathways as a Potential Therapeutic Target in Cardiovascular Disease
Seyed Mostafa Parizadeh1, Maryam Ghandehari1, Motahareh Heydari-Majd1
1Metabolic syndrome Research center, Mashhad University of Medical Sciences, Mashhad, Iran.
Insights
Cardiovascular diseases (CVD) involve the immune system, particularly Toll-like receptors (TLRs). Targeting TLRs may offer new therapeutic strategies for treating CVD, including heart failure.
Area of Science:
- Immunology
- Cardiology
- Molecular Biology
Background:
- Cardiovascular disease (CVD) is a leading cause of death and disability worldwide.
- The immune system plays a critical role in the development of CVD.
- Toll-like receptors (TLRs) are key components of the innate immune system.
Purpose of the Study:
- To review recent research on the role of TLRs in CVD.
- To explore the potential of TLR signaling pathways as therapeutic targets for CVD.
Main Methods:
- Literature review of studies investigating TLRs in CVD.
- Analysis of TLR involvement in atherogenesis, myocardial infarction, and heart failure.
Main Results:
- TLRs are implicated in various CVD pathologies, including atherosclerosis, stroke, and myocardial infarction.
- TLR signaling pathways are involved in cardiac remodeling and the development of heart failure.
- Emerging evidence suggests TLRs are crucial in the pathophysiology of CVD.
Conclusions:
- TLRs are significant players in the development and progression of CVD.
- Targeting TLR signaling pathways presents a promising therapeutic avenue for CVD treatment.
Abstract:
Cardiovascular Disease (CVD) is one of the most important causes of morbidity and mortality, and associated with an important economic burden globally. Over the last decade, the prevalence of CVD has been rising globally, and is now associated with millions of death annually in both developed and developing countries. There is good evidence that the immune system is involved in the pathophysiology of CVD. Toll-like receptors (TLRs) and their down-stream signaling pathways play an important role in the immune system. Recent studies have suggested that the TLRs are involved in atherogenesis, including stroke, myocardial infarction, ischemiareperfusion injury, cardiac remodeling and development of Heart Failure (HF). In this review we have summarized the recent studies investigating the role of TLRs in CVD and the potential for using TLRs signaling pathways as a therapeutic target in CVD.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways

